the total ( number of units for the Part D rebatable drug for the applicable period as determined under proposed 428.203 (which would remove units when a generic drug is no longer a Part D rebatable drug in proposed 428.203(b)(1) and would exclude units acquired through the 340B Program in proposed 428.203(b)(2))
In the case of an individual with diabetes who also has a diagnosis of periodontitis, oral services and treatment to address the periodontitis potentially lead to a reduction in HbA1c, a marker of glycemic control that may be used to determine the effectiveness of interventions for treatment of diabetes
Jeffrey Esaias resigned in late May from Novae Corp., a trailer manufacturing company with locations in Clarinda and Red Oak
Mean Shared Savings Program spending is expected to be reduced by $320 million over the next ten years as a result of the HEBA, if finalized
Enjoy the variety and convenience of a mixpackbut Grizzlier
Feasible Clinical ImplementationMeasures that will be used for clinical decision making can be integrated into the clinical workflow with minimal cost and administrative burden